Fidelity Investments’s Starling Oncology STLN Stock Holding History
Bought
Maintained
Sold
Other funds holding STLN
JAIC
Fidelity Investments's STLN Position: Q3 2026 in Review
Fidelity Investments increased its Starling Oncology (STLN) stake by 1,359% in Q3 2026, buying an estimated $6.34M and bringing the position to 1,139,452 shares worth $7.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2305.
Fidelity Investments first reported a position in STLN in Q4 2021 and has held it in 18 quarters since. The position peaked at $111M in Q4 2021. 131 funds tracked by Wall St. Rank hold STLN as of Q3 2026.
- Fidelity Investments held 1,139,452 shares of Starling Oncology worth $7.2M as of Q3 2026.
- Fidelity Investments bought 1,061,345 Starling Oncology shares in Q3 2026, an estimated $6.34M.
- Starling Oncology made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #2305 holding.
- Fidelity Investments first reported a position in Starling Oncology in Q4 2021 and has held it in 18 quarters since.
- Fidelity Investments's Starling Oncology position peaked at $111M in Q4 2021.
- 131 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.
Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.